Ventricular, but not atrial, M2-muscarinic receptors increase in the canine pacing-overdrive model of heart failure;LES RECEPTEURS M2-MUSCARINIQUES VENTRICULAIRES AUGMENTENT DANS UN MODELE D'ENTRAINEMENT ELECTROSYSTOLIQUE RAPIDE CANIN D'INSUFFISANCE CARDIAQUE

Canadian Journal of Cardiology

Volumn 12, Issue 1, 1996, Pages 71-76

  Wilkinson, Michael ^a   Giles, Alice ^b   Armour, J Andrew ^b   Cardinal, René ^b  

^a Grace Maternity Hospital   (Canada)

^b NONE

Author keywords

3H N methyl scopolamine; Cardiac micropunches; Heart failure

Indexed keywords

LIGAND; MUSCARINIC M2 RECEPTOR; METHYLSCOPOLAMINE; MUSCARINIC RECEPTOR; SCOPOLAMINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOG; ELECTRODE; FEMALE; HEART FAILURE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART MUSCLE CELL; HEART VENTRICLE PACING; MALE; NONHUMAN; PACEMAKER; TIME; ANIMAL; BINDING SITE; CONGESTIVE HEART FAILURE; DISEASE MODEL; HEART ATRIUM; HEART PACING; HEART VENTRICLE; PATHOLOGY;

ANIMALS; BINDING SITES; CARDIAC PACING, ARTIFICIAL; DISEASE MODELS, ANIMAL; DOGS; FEMALE; HEART ATRIA; HEART FAILURE, CONGESTIVE; HEART VENTRICLES; MALE; N-METHYLSCOPOLAMINE; RECEPTORS, MUSCARINIC; SCOPOLAMINE DERIVATIVES;

EID: 0029684944     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Kiuchi K, Shannon RP, Komamura K, et al. Myocardial β-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest 1993;91:907-14.
2. Calderone A, Bouvier M, Li K, et al. Dysfunction of the β- and α-adrenergic systems in a model of congestive heart failure. The pacing-overdrive dog. Circulation Res 1991;69:332-43.
3. 2-adreno- receptors in the human heart: properties, function and alterations in chronic heart failure. Pharmacol Rev 1991;43:203-42.
4. Eckberg DL, Drabinsky M, Braunwald E. Defective cardiac parasympathetic control in patients with heart disease. N Engl J Med 1971;285:877-83.
5. Mansier P, Chevalier B, Barnett DB, et al. Beta adrenergic and muscarinic receptors in compensatory cardiac hypertrophy of the adult rat. Pflügers Arch 1993;424:354-60.
6. Deighton NM, Zerkowski HR, Brodde OE. Muscarinic receptor number and functional responsiveness in patients with mild-to-moderate or end-stage heart failure. Eur Heart J 1990;11(Suppl A-I):367.
7. Böhm M, Gierschik P, Jakobs KH, et al. Increase of Giα in human hearts with dilated but not ischemic cardiomyopathy. Circulation 1990;82:1249-65.
8. Vatner DE, Lee DL, Schwartz KR, et al. Impaired cardiac muscarinic receptor function in dogs with heart failure. J Clin Invest 1988;81:1836-42.
9. Wilkinson M, Jacobson W, Watson-Wright WM. Tissue slices in radioligand binding assays: studies in brain, pineal and muscle. Life Sci 1986;39:2037-48.
10. 3H]CGP-12177) binding in myocardial slices of cardiomyopathic hamsters. Can J Cardiol 1989;5:175-80.
11. Watson-Wright WM, Wilkinson M. The muscle slice - a new preparation for the characterization of β-adrenergic binding in fast- and slow-twitch skeletal muscle. Muscle Nerve 1986;9:416-22.
12. Van Huizen F, Shaw C, Wilkinson M, et al. Characterization of muscarinic acetylcholine receptors in rat cerebral cortex slices with concomitant morphological and physiological assessment of tissue viability. Mol Brain Res 1989;5:59-69.
13. Wilkinson M, MacDonald MC, Landymore K, et al. Opioid receptors in micropunches of fresh hypothalamic tissue: a binding assay for Everyman. In: Greenstein B, ed. Neuroendocrine Research Methods. London: Harwood, 1991:723-46.
14. 3H] N-methyl scopolamine) binding in micropunches of rat ventricular myocardium: characterization and modification by progesterone. Can J Physiol Pharmacol 1993;70:943-8.
15. Jose AD, Taylor RR. Autonomic blockade by propranolol and atropine to study intrinsic myocardial function in man. J Clin Invest 1969;48:2019-31.
16. Higgins CB, Vatner DL, Eckberg L, et al. Alterations in the baroreceptor reflex in conscious dogs with heart failure. J Clin Invest 1972;51:715-24.
17. Armour JA, Randall WC. Rebound cardiovascular responses following stimulation of canine vagosympathetic complexes on cardiopulmonary nerves. Can J Physiol Pharmacol 1985;63:1122-32.
18. 3H] AF-DX 384. Biochem Pharmacol 1990;40:1674-6.
19. Zivin JA, Waud DR. How to analyze binding, enzyme and uptake data: the simplest case, a single phase. Life Sci 1982;30:1407-22.
20. Delmendo RE, Michel AD, Whiting RL. Affinity of muscarinic receptor antagonists for three putative muscarinic receptor binding sites. Br J Pharmacol 1989;96:457-64.
21. Tucek S, Musilkova J, Nedoma J, et al. Positive cooperativity in the binding of Alcuronium and N-methylscopol- amine to muscarinic acetylcholine receptors. Mol Pharmacol 1990;38:674-80.
22. 2 receptor binding. Relationship with functional efficacy. Eur J Pharmacol 1988;156:133-42.
23. Giraldo E, Martos F, Gomez A, et al. Characterization of muscarinic receptor subtypes in human tissues. Life Sci 1988;43:1507-15.
24. Deighton NM, Motomura S, Borquez D, et al. Muscarinic cholinoceptots in the human heart demonstration, subclassification, and distribution. Naunyn Schmiedebergs Arch Pharmacol 1990;341:14-21.
25. Colvin RA, Oibo JA, Allen RA, et al. Interaction of amidarone and desethylamidorone with the cardiac muscarinic receptor in vitro. J Mol Cell Cardiol 1989;21:453-60.
26. 3H] NMS) receptors in isolated ventricular myocytes from rat. J Mol Cell Cardiol 1990;22:1273-83.
27. Dashwood MR, Polak JM, Power RF, et al. Autoradiographic localization of adrenergic and muscarinic cholinergic receptors in human atrial tissue. J Physiol 1987;392:89.
28. Reithmann C, Panzner B, Werdan K. Distinct pathways for β-adreno-receptor-induced up-regulation of muscarinic acetylcholine receptors and inhibitory G-protein α-subunits in chicken cardiomyocytes. Naunyn Schmiedebergs Arch Pharmacol 1992;345:530-40.
29. Levett J, Marinelli CC, Lund DD, et al. Effects of β-blockade on neurohumoral responses and neurochemical markers in pacing-induced heart failure. Am J Physiol 1994;266:H468-75.
30. Eschenhagen T, Mende U, Nose M, et al. Isoprenaline-induced increase in mRNA levels of inhibitory G-protein α-subunits in rat heart. Naunyn Schmiedebergs Arch Pharmacol 1991;343:609-15.
31. iα-2 in human end-stage heart failure. Circ Res 1992;70:688-96.